A major discovery in cancer research is emerging with the use of VHH fragments to re-engage mutated p53. This crucial malignant protector protein is frequently inactivated in many kinds of malignancies, resulting https://kingbookmark.com/story22008445/nanobodies-revive-tumor-suppressor-p53-the-new-pathway-for-malignant-treatment